Pathogenic germline variants in Chinese pancreatic adenocarcinoma patients
Abstract Putting pancreatic adenocarcinoma (PAAD) screening into perspective for high-risk individuals could significantly reduce cancer morbidity and mortality. Previous studies have profiled somatic mutations in PAAD. In contrast, the prevalence of mutations in PAAD predisposition genes has not be...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-03-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-025-57520-3 |